Key statistics
On Friday, Aptargroup Inc (ATR:NYQ) closed at 160.58, -0.60% below its 52-week high of 161.55, set on Sep 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 159.94 |
---|---|
High | 161.47 |
Low | 159.33 |
Bid | 159.90 |
Offer | 160.91 |
Previous close | 158.94 |
Average volume | 295.84k |
---|---|
Shares outstanding | 66.39m |
Free float | 66.01m |
P/E (TTM) | 33.74 |
Market cap | 10.66bn USD |
EPS (TTM) | 4.76 USD |
Annual div (ADY) | 1.80 USD |
---|---|
Annual div yield (ADY) | 1.12% |
Div ex-date | Jul 25 2024 |
Div pay-date | Aug 15 2024 |
Data delayed at least 15 minutes, as of Oct 05 2024 00:00 BST.
More ▼
Press releases
- Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
- Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
- Daniel Ackerman Named Aptar’s Chief Accounting Officer
- Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company
- Aptar Reports Second Quarter 2024 Results
- Aptar Increases Quarterly Dividend by Nearly 10% Due to Continued Strong Performance
More ▼